{"id":"NCT03345342","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study of Paliperidone Palmitate 6-Month Formulation","officialTitle":"A Double-blind, Randomized, Active-controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-11-20","primaryCompletion":"2020-05-08","completion":"2020-05-08","firstPosted":"2017-11-17","resultsPosted":"2021-12-09","lastUpdate":"2025-04-29"},"enrollment":841,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Schizophrenia"],"interventions":[{"type":"DRUG","name":"PP6M","otherNames":["R092670"]},{"type":"DRUG","name":"PP3M 350 mg eq.","otherNames":["R092670"]},{"type":"DRUG","name":"PP3M 525 mg eq.","otherNames":["R092670"]},{"type":"DRUG","name":"PP1M","otherNames":["R092670"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"PP1M: Transition Phase","type":"EXPERIMENTAL"},{"label":"PP1M/PP3M: Maintenance Phase","type":"EXPERIMENTAL"},{"label":"PP6M or Placebo: Double-Blind Phase","type":"EXPERIMENTAL"},{"label":"PP3M: Double-Blind Phase","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to demonstrate that injection cycles consisting of a single administration of paliperidone palmitate 6-month (PP6M) are not less effective than 2 sequentially administered injections of paliperidone palmitate 3-month PP3M) (350 or 525 mg eq.) for the prevention of relapse in participants with schizophrenia previously stabilized on corresponding doses of paliperidone palmitate 1-month (PP1M) (100 or 150 mg eq.) or PP3M (350 or 525 mg eq.).","primaryOutcome":{"measure":"Time to Relapse During the Double-Blind (DB) Phase","timeFrame":"Up to 12 months of DB Phase","effectByArm":[{"arm":"DB PP3M","deltaMin":null,"sd":null},{"arm":"DB PP6M","deltaMin":null,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":138,"countries":["United States","Argentina","Australia","Brazil","Bulgaria","Czechia","France","Hong Kong","Hungary","India","Italy","Malaysia","Mexico","Poland","Russia","South Africa","South Korea","Spain","Taiwan","Turkey (TÃ¼rkiye)","Ukraine"]},"refs":{"pmids":["37653768","37480362","34791283"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":23,"n":838},"commonTop":["Injection Site Pain","Weight Increased","Nasopharyngitis","Headache","Upper Respiratory Tract Infection"]}}